How can residents maximize their surgical skills development and personal growth during the grueling years of urology residency? In the second edition of the BackTable Urology podcast’s PGY Playlist series, host Dr. Gina Badalato interviews Dr. George Moran, a chief resident from Columbia University, about his recommended strategies.

---

SYNPOSIS

Dr. Moran shares his approach to studying medical guidelines, using the spaced repetition app, Anki, and preparing for the annual in-service exam. The doctors also discuss GAMERS, a surgical simulation competition started by Dr. Moran intended to improve robotic skills. Finally, Dr. Moran speaks to the importance of adaptability, personalization, and mentorship in effective learning during residency.

---

TIMESTAMPS

00:00 - Introduction

02:38 - Strategies for Learning Medical Knowledge

09:08 - Preparing for Exams

16:14 - Robotic Simulation

21:46 - Final Wisdom

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros Grivas from Fred Hutchinson Cancer Center and Dr. Sumanta (Monty) Pal from City of Hope.

---

CHECK OUT OUR SPONSOR

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

---

SYNPOSIS

The conversation initially focuses on advanced urothelial carcinoma and the EV302 trial, discussing detailed insights from the quality-of-life results presented at ASCO. The experts offer relevant clinical perspectives for modern metastatic urothelial carcinoma management, focusing on pembrolizumab plus enfortumab vedotin. Further, they delve into breaking biomarker research at ASCO, including KIM-1 in adjuvant renal cell carcinoma (RCC) therapy and the HIF-2 inhibitor DFF332 for chromophobe RCC.

---

TIMESTAMPS

00:00 - Introduction

03:42 - Pembrolizumab and Enfortumab Vedotin Trial Insights

07:43 - Future Trials and Treatment Strategies

21:27 - Javelin Bladder 100 Trial Discussion

32:05 - Growth Factor Use

36:21 - Future Directions of Biomarkers

38:55 - Kidney Cancer Biomarker Trials

53:40 - Concluding Thoughts

In this episode of the BackTable Urology Podcast, Dr. Ashish Kamat discusses contemporary management of high-risk, non-muscle-invasive bladder cancer (NMIBC) and his thoughts into the future of this arena.

---

CHECK OUT OUR SPONSOR

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

---

SYNPOSIS

Dr. Kamat explores the evolving role of BCG and potential alternative therapies such as gemcitabine and docetaxel. He also covers effective clinical management, emerging clinical trials, and nuanced decision-making principles for radical cystectomy. Finally, the conversation touches on Dr. Kamat’s expert insights regarding the future of NMIBC management, including predictive biomarkers and personalized medicine.

---

TIMESTAMPS

00:00 - Introduction

03:56 - Initial Diagnosis and Workup

12:22 - High-Grade Bladder Cancer

22:37 - BCG and Alternative Treatments

31:30 - BCG Unresponsive Disease

36:56 - Novel Intravesical and Systemic Therapies

46:45 - Future Directions

---

RESOURCES

Related BackTable episodes:

https://www.backtable.com/shows/urology/podcasts/64/management-of-bcg-refractory-nmibc

https://www.backtable.com/shows/urology/podcasts/157/the-bladder-cancer-matters-podcast

https://www.backtable.com/shows/urology/podcasts/103/adjuvant-therapy-for-high-risk-bladder-cancer

Dr. Charla Holdren, a resident at the University of Michigan-West, and Dr. Christine Van Horn, an endourology fellow at Loyola, explore the high rates of infertility and pregnancy complications among female urologists.

---

CHECK OUT OUR SPONSOR

Fellow

https://www.meetfellow.com/

---

SYNPOSIS

First, the two experts discuss personal experiences in family planning and challenges faced regularly in the hospital environment. They outline the complexities of assisted reproductive technology and offer insights for a better path forward, including cultural shifts, new policies, and supportive resources to better accommodate the needs of female surgeons.

---

TIMESTAMPS

00:00 - Introduction

04:05 - Dr. Holdren and Dr. Van Horn’s Journeys

06:57 - Challenges in Family Planning

17:51 - Parental Leave Policies

26:56 - Advanced Reproductive Technology

33:46 - Looking Towards the Future

---

RESOURCES

Fellow

https://www.meetfellow.com/

As part of our recurring resident-focused series "PGY Playlist", guest hosts Dr. Lindsay Hampson (UCSF) and Dr. Gina Badalato (Columbia) speak with Onyi Ibeziako, a third-year resident at UT Southwestern, about effectively handling challenges during the early years of urology residency.

---

SYNPOSIS

Dr. Ibeziako offers practical advice on managing competing responsibilities, building relationships with hospital staff, and developing early surgical skills. She offers valuable personal insights on self-directed study, triage of tasks, and making the most of these valuable years to set up for a successful career ahead.

---

TIMESTAMPS

00:00 - Introduction

05:43 - Early Residency Challenges

10:51 - Relationships with Nursing

14:23 - Multitasking

24:06 - Developing Surgical Skills as an Intern

33:09 - Continuous Learning and Final Pearls of Wisdom

In this episode of the BackTable Urology Podcast, Dr. Jose Silva and Dr. Spencer Hiller discuss holmium laser enucleation of the prostate (HoLEP), including preoperative and postoperative care, and the technical nuances of the procedure.

---

CHECK OUT OUR SPONSOR

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

---

SYNPOSIS

Dr. Hiller emphasizes the importance of patient education, bladder retraining, and the holistic management of incontinence. The conversation also touches on the science of lasers, effective morcellation, and practical challenges in achieving successful outcomes.

---

TIMESTAMPS

00:00 - Introduction

07:58 - HoLEP Patient Counseling

21:29 - HoLEP Surgical Techniques

33:54 - Morcellation: Challenges and Best Practices

37:16 - Post-Operative Care

47:21 - Postoperative Urinary Symptoms

Dr. Aditya Bagrodia sits down with Elie Toubiana, founder and CEO of ScribeMD.ai, to discuss the transformative potential of artificial intelligence (AI) in medical documentation.

---

SYNPOSIS

Their conversation covers the capabilities and benefits of using an AI-driven medical scribe that ensures HIPAA compliance, reduces physician burnout, and enhances patient interactions. Elie also shares his insights about the technology’s adaptability across various medical fields. Finally, Dr. Bagrodia and Elie discuss ethical considerations surrounding applications of AI in other aspects of healthcare, such as medical workup and diagnosis.

---

TIMESTAMPS

00:00 - Introduction

06:00 - How ScribeMD AI Works

14:14 - Integration with EMR

20:31 - Legal Considerations with AI Technology

26:34 - Cost Implications of AI Scribes

38:46 - Future of AI in Medical Diagnosis

41:45 - Conclusion and Final Thoughts

---

RESOURCES

ScribeMD.ai

https://www.scribemd.ai/

In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024.

---

CHECK OUT OUR SPONSOR

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

First, the doctors cover noteworthy topics, including the effectiveness of early screening and treatment for high-risk prostate cancer patients, innovative approaches in imaging and biomarkers, and the impact of new guidelines on salvage therapy. They also explore emerging treatments for non-muscle invasive bladder cancer (NMIBC), as well as the evolving role of systemic immunotherapies and advanced genomic testing. To wrap up, the urologists offer detailed analyses and their expert opinions on how these developments could transform patient care in the field of urologic oncology.

---

TIMESTAMPS

00:00 - Introductions

03:06 - Prostate Cancer Screening Insights

10:10 - Advancements in MRI and Biomarkers

18:22 - Transperineal vs. Transrectal Prostate Biopsy

27:18 - New Guidelines for Bladder Cancer Treatment

30:57 - Innovative Drug Delivery Systems

32:36 - Gene Therapy and Immunotherapy Advances

40:11 - Concluding Thoughts and Future Prospects

---

RESOURCES

Decipher Prostate Genomic Classifier by Veracyte:

​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

In this episode of Back Table Urology, Dr. Aditya Bagrodia, Dr. Joshua Langston, and Dr. Mara Holton from the Large Urology Group Practice Association (LUGPA) share insights on the financial and administrative complexities that urologists face.

---

CHECK OUT OUR SPONSOR

Fellow

https://www.meetfellow.com/

---

SYNPOSIS

The doctors delve into the increasing costs of healthcare, the challenges posed by regulatory requirements, and the significance of physician leadership in influencing healthcare delivery. The discussion also highlights the importance of advocacy, the evolving role of physicians in business and policy, and actionable steps doctors can take to ensure their voices are heard. Finally, the doctors address the growing trend of hospital employment among physicians and its impact on rural healthcare access.

---

TIMESTAMPS

00:00 - Introduction

06:41 - Complexities and Costs in Healthcare

11:48 - The Role of Physicians in Healthcare Leadership

17:21 - The Shift Towards Hospital Employment

27:35 - Economic Pressures on Physicians and Patients

30:09 - Cost Discrepancies in Medical Procedures

38:16 - Burnout and Workforce Challenges

49:26 - Advocacy and Call to Action

---

RESOURCES

Fellow

https://www.meetfellow.com/

BackTable URO Ep. 82- Advocacy Basics for the Urologist: From Your Clinic to Capitol Hill with Dr. Ruchika Talwar

https://open.spotify.com/episode/0hcLrKuf5QU7TZCHSErs4Z?si=842c7985f44c4e04

BackTable URO Ep. 164: Urology Advocacy: From Passion to Policy with Dr. Seth Cohen, Dr. Michelle Leach, and Dr. Suzette Sutherland

https://open.spotify.com/episode/68pR7MxFIgQ1HJLy6xQHDX?si=36a93eedd6594770

In this episode of BackTable Urology, host Dr. Aditya Bagrodia, urologic oncologist Dr. Philippe Speiss (Moffitt Cancer Center), and medical oncologist Dr. Andrea Necchi (Università Vita-Salute San Raffaele) have an in-depth discussion about the mission and achievements of the Global Society of Rare Genitourinary Tumors (GSRGT).

---

CHECK OUT OUR SPONSORS

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

First, the doctors discuss the society’s mission to improve the diagnosis and treatment of rare genitourinary cancers globally. They give an overview of their educational efforts, international collaborations, and significant achievements in clinical research. The discussion also covers the importance of global representation, the challenges of studying rare tumors, and future directions, such as leveraging artificial intelligence. The episode concludes with an emphasis on the society’s commitment to being inclusive and providing opportunities for young investigators.

---

TIMESTAMPS

00:00 - Introduction

06:45 - Origins and Missions of GSRGT

11:21 - Challenges in Rare Cancer Research

31:51 - Future Directions in Rare Cancer Treatment

38:38 - How to Get Involved with GSRGT

---

RESOURCES

Siemens Healthineers Theranostics:

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Decipher Prostate Genomic Classifier by Veracyte:

​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

GSRGT Website

https://www.gsrgt.com/

Andrea Necchi Website

https://www.andreanecchi.com/